Furlow Palatoplasty With Tensor Tenopexy
Primary Purpose
Otitis Media, Cleft Palate
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
palatoplasty
Sponsored by
About this trial
This is an interventional treatment trial for Otitis Media focused on measuring otitis media, cleft palate
Eligibility Criteria
Inclusion Criteria:
- cleft palate with or without cleft lip classified as Veau I through IV
- parental consent for procedure
- patients assigned to Drs. Losee, Davit, Grundwaldt, or Goldstein for palatoplasty
- children up to 15 months of age who have not had palatoplasty but have tympanostomy tubes
Exclusion Criteria:
- patients with syndromic clefts or genetic abnormalities
Sites / Locations
- Children's Hospital of Pittsburgh of UPMC
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Furlow palatoplasty
modified Furlow palatoplasty
Arm Description
standard procedure
standard procedure plus modification
Outcomes
Primary Outcome Measures
hearing status
results of audiometric testing
otitis media status
diagnosis of OM, presence/absence of ventilation tubes at time of 3-year visit
Eustachian tube function (ETF) measures
ETF test results
Secondary Outcome Measures
Pittsburgh Weighted Speech Score
obtained as standard of care
nasalence ratio
obtained as standard of care
McKay-Kummer SMAP test
obtained as standard of care
duration of speech therapy
need for revision palatoplasties
Full Information
NCT ID
NCT01535131
First Posted
February 7, 2012
Last Updated
July 29, 2022
Sponsor
University of Pittsburgh
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)
1. Study Identification
Unique Protocol Identification Number
NCT01535131
Brief Title
Furlow Palatoplasty With Tensor Tenopexy
Official Title
Furlow Palatoplasty With Tensor Tenopexy for Otitis Media
Study Type
Interventional
2. Study Status
Record Verification Date
July 2022
Overall Recruitment Status
Completed
Study Start Date
February 28, 2012 (Actual)
Primary Completion Date
December 23, 2019 (Actual)
Study Completion Date
June 30, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh
Collaborators
National Institute on Deafness and Other Communication Disorders (NIDCD)
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study compares a standard method for palate repair (the Furlow palatoplasty) with a modification of that method to determine which, if either, is more effective in reducing the duration of middle-ear disease (fluid in the ear) in cleft palate patients.
Detailed Description
Almost all infants and young children who were born with a cleft palate (with or without a cleft lip) have middle-ear disease and this condition can last into late childhood and early adolescence. The type of middle-ear disease that usually occurs in cleft palate patients is not associated with pain or symptoms, but the fluid in the middle-ear causes poor hearing and sometimes problems with balance.
Past studies show that the middle-ear disease in infants and children with cleft palate is caused by their inability to open a natural tube that connects the back of the nose with the middle-ear (called the Eustachian tube). Opening the Eustachian tube is required to keep the pressure in the middle-ear equal to that of the atmosphere which prevents fluid from building up in the middle-ear. For this reason, middle-ear disease is usually treated by placing a small plastic tube in the eardrum which keeps the middle-ear pressure and pressure in the room (atmospheric pressure) equal even when the Eustachian tube fails to open. However, the disease often returns when the plastic tube becomes blocked or falls out and a new tube needs to be placed in the eardrum. The actions of two small muscles, the levator veli palatini (LVP) muscle and the tensor veli palatini (TVP) muscle combine to open the Eustachian tube and the LVP muscle plays a role in raising the palate during speech, swallowing and other activities. Both muscles run through the soft palate. In children with cleft palate, the usual position, orientation and function of both of these muscles are abnormal and few surgical procedures for palate repair focus on re-establishing a more "normal" orientation and attachment of these muscles.
One well accepted method for repair of the palate, the Furlow palatoplasty is the standard procedure used by the two cleft palate surgeons involved in this study. During the Furlow palatoplasty the attachment of the TVP muscle is cut. Recently, a modification of the Furlow palatoplasty, called a tensor tenopexy, has been described that involves attaching the cut part of the TVP muscle to a bony hook in the soft palate in an effort to improve Eustachian tube function and lead to less middle-ear disease. One small study presented results suggesting that middle-ear disease was cured at an earlier age in those cleft palate patients who had their palates repaired using the modified Furlow procedure when compared to a number of other methods of palate repair, but these comparisons did not include the standard Furlow procedure. However, the design of that study was poor and the possible benefits of this small modification in the surgical procedure with respect to middle-ear disease need to be evaluated in a more formal study. Because the surgical procedures for the Furlow palatoplasty and the modified Furlow procedure are identical with the exception of the addition of anchoring the cut muscle attachment, a study of these two procedures will allow us to determine if the modified procedure does or does not improve middle-ear disease at an earlier age in patients with cleft palate.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Otitis Media, Cleft Palate
Keywords
otitis media, cleft palate
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
83 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Furlow palatoplasty
Arm Type
Active Comparator
Arm Description
standard procedure
Arm Title
modified Furlow palatoplasty
Arm Type
Experimental
Arm Description
standard procedure plus modification
Intervention Type
Procedure
Intervention Name(s)
palatoplasty
Intervention Description
procedure to close cleft palate
Primary Outcome Measure Information:
Title
hearing status
Description
results of audiometric testing
Time Frame
3-year visit
Title
otitis media status
Description
diagnosis of OM, presence/absence of ventilation tubes at time of 3-year visit
Time Frame
3 years of age
Title
Eustachian tube function (ETF) measures
Description
ETF test results
Time Frame
3-year visit
Secondary Outcome Measure Information:
Title
Pittsburgh Weighted Speech Score
Description
obtained as standard of care
Time Frame
3 years of age
Title
nasalence ratio
Description
obtained as standard of care
Time Frame
3 years of age
Title
McKay-Kummer SMAP test
Description
obtained as standard of care
Time Frame
3 years of age
Title
duration of speech therapy
Time Frame
by age 7 years
Title
need for revision palatoplasties
Time Frame
by 7 years of age
10. Eligibility
Sex
All
Maximum Age & Unit of Time
15 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
cleft palate with or without cleft lip classified as Veau I through IV
parental consent for procedure
patients assigned to Drs. Losee, Davit, Grundwaldt, or Goldstein for palatoplasty
children up to 15 months of age who have not had palatoplasty but have tympanostomy tubes
Exclusion Criteria:
patients with syndromic clefts or genetic abnormalities
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cuneyt M Alper, MD
Organizational Affiliation
University of Pittsburgh
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital of Pittsburgh of UPMC
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15224
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Furlow Palatoplasty With Tensor Tenopexy
We'll reach out to this number within 24 hrs